An estimated quantitative lateral flow immunoassay for determination of artesunate using monoclonal antibody.
There was the report of the falsified artesunate (ART) which has led to deaths from untreated malaria in South East Asia. To rapidly screen of the fake and adulterated ART products in the drug market, a lateral flow immunoassay (LFIA) based on colloidal gold-monoclonal antibody probe for detection of ART within samples was developed. With this method, the calibration curve of ART was performed by the intensity ratio of the test and control bands in various ART concentrations. The linearity range was 12.5 - 200 μg/mL of ART. Samples were tested by the developed LFIA and can be calculated for ART contents. The level of ART in the samples were also confirmed by ELISA. The results of the two methods were in good conformance. The proposed LFIA was demonstrated to be a simple and rapid analytical method for detecting ART in the pharmaceutical formulation.